S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
66,000% upside on tiny biotech? (Ad)
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
Who is Arthur Engoron? Judge weighing future of Donald Trump empire is Ivy League-educated ex-cabbie
66,000% upside on tiny biotech? (Ad)
Federal agency sues Chipotle after a Kansas manager allegedly ripped off an employee's hijab
Apple says it will fix software problems blamed for making iPhone 15 models too hot to handle
The single greatest medical breakthrough of all time? (Ad)
Native Hawaiian neighborhood survived Maui fire. Lahaina locals praise its cultural significance
A fight over precious groundwater in a rural California town is rooted in carrots
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
66,000% upside on tiny biotech? (Ad)
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
Who is Arthur Engoron? Judge weighing future of Donald Trump empire is Ivy League-educated ex-cabbie
66,000% upside on tiny biotech? (Ad)
Federal agency sues Chipotle after a Kansas manager allegedly ripped off an employee's hijab
Apple says it will fix software problems blamed for making iPhone 15 models too hot to handle
The single greatest medical breakthrough of all time? (Ad)
Native Hawaiian neighborhood survived Maui fire. Lahaina locals praise its cultural significance
A fight over precious groundwater in a rural California town is rooted in carrots
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
66,000% upside on tiny biotech? (Ad)
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
Who is Arthur Engoron? Judge weighing future of Donald Trump empire is Ivy League-educated ex-cabbie
66,000% upside on tiny biotech? (Ad)
Federal agency sues Chipotle after a Kansas manager allegedly ripped off an employee's hijab
Apple says it will fix software problems blamed for making iPhone 15 models too hot to handle
The single greatest medical breakthrough of all time? (Ad)
Native Hawaiian neighborhood survived Maui fire. Lahaina locals praise its cultural significance
A fight over precious groundwater in a rural California town is rooted in carrots
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
66,000% upside on tiny biotech? (Ad)
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
Who is Arthur Engoron? Judge weighing future of Donald Trump empire is Ivy League-educated ex-cabbie
66,000% upside on tiny biotech? (Ad)
Federal agency sues Chipotle after a Kansas manager allegedly ripped off an employee's hijab
Apple says it will fix software problems blamed for making iPhone 15 models too hot to handle
The single greatest medical breakthrough of all time? (Ad)
Native Hawaiian neighborhood survived Maui fire. Lahaina locals praise its cultural significance
A fight over precious groundwater in a rural California town is rooted in carrots

Prestige Consumer Healthcare (PBH) Stock Forecast, Price & News

$57.19
-1.84 (-3.12%)
(As of 09/29/2023 ET)
Compare
Today's Range
$56.79
$59.13
50-Day Range
$56.66
$68.31
52-Week Range
$49.00
$68.54
Volume
270,337 shs
Average Volume
233,369 shs
Market Capitalization
$2.83 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$82.00

Prestige Consumer Healthcare MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.67 Rating Score
Upside/​Downside
43.4% Upside
$82.00 Price Target
Short Interest
Bearish
3.12% of Float Sold Short
Dividend Strength
N/A
Sustainability
-2.35
Upright™ Environmental Score
News Sentiment
1.73mentions of Prestige Consumer Healthcare in the last 14 days
Based on 5 Articles This Week
Insider Trading
Selling Shares
$2.30 M Sold Last Quarter
Proj. Earnings Growth
6.73%
From $4.31 to $4.60 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.25 out of 5 stars

Medical Sector

375th out of 971 stocks

Pharmaceutical Preparations Industry

160th out of 457 stocks


PBH stock logo

About Prestige Consumer Healthcare (NYSE:PBH) Stock

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear wax removals, and Dramamine for motion sickness relief. The company also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Summer's Eve feminine hygiene, TheraTears dry eye relief, Fess nasal saline spray and washes, and Hydralyte for oral rehydration products. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.

PBH Price History

PBH Stock News Headlines

Prestige Consumer Healthcare (NYSE:PBH) Shares Down 3.5%
This Stock Could Go Up 66% or More.
Marc Chaikin built the system that isolated NVDA before it became the best-performing stock of 2023.  Click here to get his latest buy.  More here.
This Stock Could Go Up 66% or More.
Marc Chaikin built the system that isolated NVDA before it became the best-performing stock of 2023.  Click here to get his latest buy.  More here.
Prestige Brands Holdings, Inc. (PBH)
See More Headlines
Receive PBH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Prestige Consumer Healthcare and its competitors with MarketBeat's FREE daily newsletter.

PBH Company Calendar

Last Earnings
8/03/2023
Today
10/01/2023
Next Earnings (Estimated)
11/02/2023
Fiscal Year End
3/31/2024

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
Personal Products
Sector
Medical
CUSIP
74112D10
Employees
560
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$82.00
High Stock Price Forecast
$104.00
Low Stock Price Forecast
$71.00
Forecasted Upside/Downside
+43.4%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
3 Analysts

Profitability

Net Income
$-82,310,000.00
Pretax Margin
-8.50%

Debt

Sales & Book Value

Annual Sales
$1.13 billion
Cash Flow
$5.01 per share
Book Value
$29.12 per share

Miscellaneous

Free Float
48,746,000
Market Cap
$2.83 billion
Optionable
Optionable
Beta
0.59
7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Key Executives

  • Mr. Ronald M. LombardiMr. Ronald M. Lombardi (Age 59)
    Chairman, Pres & CEO
    Comp: $1.98M
  • Ms. Christine Sacco (Age 47)
    Chief Financial Officer
    Comp: $958.91k
  • Mr. Jeffrey Zerillo (Age 62)
    Sr. VP of Operations
    Comp: $496.91k
  • Mr. William C. P'Pool (Age 58)
    Sr. VP, Gen. Counsel & Corp. Sec.
    Comp: $769.98k
  • Mr. Adel Mekhail (Age 62)
    Exec. VP of Marketing & Sales
    Comp: $797.94k
  • Mr. Philip David Terpolilli
    Director of Investor Relations
  • Dean Siegal
    Director of Communications
  • Ms. Mary Beth Fritz
    Sr. VP of Quality & Regulatory Affairs













PBH Stock - Frequently Asked Questions

Should I buy or sell Prestige Consumer Healthcare stock right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Prestige Consumer Healthcare in the last twelve months. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" PBH shares.
View PBH analyst ratings
or view top-rated stocks.

What is Prestige Consumer Healthcare's stock price forecast for 2023?

3 Wall Street analysts have issued 1-year target prices for Prestige Consumer Healthcare's stock. Their PBH share price forecasts range from $71.00 to $104.00. On average, they predict the company's stock price to reach $82.00 in the next year. This suggests a possible upside of 43.4% from the stock's current price.
View analysts price targets for PBH
or view top-rated stocks among Wall Street analysts.

How have PBH shares performed in 2023?

Prestige Consumer Healthcare's stock was trading at $62.60 on January 1st, 2023. Since then, PBH stock has decreased by 8.6% and is now trading at $57.19.
View the best growth stocks for 2023 here
.

When is Prestige Consumer Healthcare's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 2nd 2023.
View our PBH earnings forecast
.

How were Prestige Consumer Healthcare's earnings last quarter?

Prestige Consumer Healthcare Inc. (NYSE:PBH) posted its earnings results on Thursday, August, 3rd. The company reported $1.06 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.01 by $0.05. The business earned $279.31 million during the quarter, compared to analyst estimates of $278.79 million. Prestige Consumer Healthcare had a positive trailing twelve-month return on equity of 13.47% and a negative net margin of 7.46%. The business's revenue for the quarter was up .8% compared to the same quarter last year. During the same period in the prior year, the business posted $1.09 earnings per share.

What guidance has Prestige Consumer Healthcare issued on next quarter's earnings?

Prestige Consumer Healthcare issued an update on its FY 2024 earnings guidance on Thursday, August, 3rd. The company provided EPS guidance of $4.27-$4.32 for the period, compared to the consensus estimate of $3.92. The company issued revenue guidance of $1.14 billion-$1.14 billion, compared to the consensus revenue estimate of $1.03 billion.

What is Ronald M. Lombardi's approval rating as Prestige Consumer Healthcare's CEO?

8 employees have rated Prestige Consumer Healthcare Chief Executive Officer Ronald M. Lombardi on Glassdoor.com. Ronald M. Lombardi has an approval rating of 61% among the company's employees. This puts Ronald M. Lombardi in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Prestige Consumer Healthcare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Prestige Consumer Healthcare investors own include Pfizer (PFE), AbbVie (ABBV), Gilead Sciences (GILD), AT&T (T), Intel (INTC), ONEOK (OKE), Wells Fargo & Company (WFC), International Business Machines (IBM), Micron Technology (MU) and Teva Pharmaceutical Industries (TEVA).

What is Prestige Consumer Healthcare's stock symbol?

Prestige Consumer Healthcare trades on the New York Stock Exchange (NYSE) under the ticker symbol "PBH."

How do I buy shares of Prestige Consumer Healthcare?

Shares of PBH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Prestige Consumer Healthcare's stock price today?

One share of PBH stock can currently be purchased for approximately $57.19.

How much money does Prestige Consumer Healthcare make?

Prestige Consumer Healthcare (NYSE:PBH) has a market capitalization of $2.83 billion and generates $1.13 billion in revenue each year. The company earns $-82,310,000.00 in net income (profit) each year or ($1.71) on an earnings per share basis.

How many employees does Prestige Consumer Healthcare have?

The company employs 560 workers across the globe.

How can I contact Prestige Consumer Healthcare?

Prestige Consumer Healthcare's mailing address is 660 WHITE PLAINS ROAD SUITE 250, TARRYTOWN NY, 10591. The official website for the company is www.prestigebrands.com. The company can be reached via phone at (914) 524-6800, via email at irinquiries@prestigebrands.com, or via fax at 302-674-5266.

This page (NYSE:PBH) was last updated on 10/1/2023 by MarketBeat.com Staff

My Account -